Marsico Capital Management LLC Repligen Corp Transaction History

Marsico Capital Management LLC

  • $3.45 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$160.42 - $256.21 $1.11 Million - $1.78 Million
6,931 Added 30.28%
29,824 $5.58 Million
Q2 2020

Aug 14, 2020
BUY
$94.33 - $140.48 $2.16 Million - $3.22 Million
22,893 New
22,893 $2.83 Million

Others Institutions Holding RGEN

# of Institutions
482
Shares Held
56.3M
Call Options Held
251K
Put Options Held
458K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.16B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Marsico Capital Management LLC Portfolio

Follow Marsico Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marsico Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email